Letrozole Reduces Estrogen and Gonadotropin Exposure in Women with Breast Cancer Undergoing Ovarian Stimulation before Chemotherapy | Zendy

Kutluk Oktay | Zendy; Ariel Hourvitz | Zendy; Gülnaz Şahin | Zendy; Özgür Öktem | Zendy; Bradley Safro | Zendy; Aylin Pelin Çil | Zendy; Heejung Bang | Zendy

Open Access

Letrozole Reduces Estrogen and Gonadotropin Exposure in Women with Breast Cancer Undergoing Ovarian Stimulation before Chemotherapy

Author(s) -

Kutluk Oktay,

Ariel Hourvitz,

Gülnaz Şahin,

Özgür Öktem,

Bradley Safro,

Aylin Pelin Çil,

Heejung Bang

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-0962

Subject(s) - fertility preservation , letrozole , breast cancer , gonadotropin , estrogen , medicine , chemotherapy , in vitro fertilisation , endocrinology , oocyte cryopreservation , human chorionic gonadotropin , gynecology , ovarian tissue cryopreservation , embryo cryopreservation , cancer , aromatase , biology , fertility , pregnancy , hormone , population , environmental health , genetics

Women with breast cancer are not typically offered embryo or oocyte cryopreservation to preserve their fertility before chemotherapy because of the potential risks associated with high estrogen levels arising from ovarian stimulation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research